Kara Lassen
Direktor/Vorstandsmitglied bei MOONLAKE IMMUNOTHERAPEUTICS
Aktive Positionen von Kara Lassen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Direktor/Vorstandsmitglied | 05.04.2022 | - |
| Independent Dir/Board Member | 05.04.2022 | - | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.04.2019 | - |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Kara Lassen
Ausbildung von Kara Lassen
| Wake Forest University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistik
International
| Schweiz | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
- Börse
- Insiders
- Kara Lassen
- Erfahrung